Bruker Cellular Analysis

What Bruker Cellular Analysis does

Bruker Cellular Analysis is a wholly-owned subsidiary of Bruker Corporation (NASDAQ: BRKR), previously operating under the name PhenomeX, headquartered in Emeryville, California, with 51-100 employees. The company develops and commercializes single-cell analysis platforms built on proprietary Opto-Electrical Positioning (OEP) technology, which combines nanofluidics with light-actuated manipulation of cells and beads inside arrays of NanoPen chambers. Its commercial portfolio comprises two integrated suites: the Optofluidic Product Suite (Beacon Discovery, Beacon Quest, Beacon, and Beacon Select instruments, plus Culture Station expansion module, kits for antibody discovery, cell line development and T cell profiling, and Cell Analysis Suite software) and the Proteomic Barcoding Suite (IsoLight and IsoSpark instruments running IsoCode chips for single-cell secretome and signaling analysis, CodePlex and Meteor bulk assays, and IsoSpeak software).

The company's products serve academic and translational research laboratories, biopharmaceutical and biotechnology companies (including Amgen), contract research and manufacturing organizations (including Catalent Biologics, Mycenax, and Abveris), and cell therapy developers working on antibody discovery, cell line development, and immune and T cell profiling. Core use cases include compressing antibody discovery timelines, accelerating cell line development by up to 4x, providing greater than 99% monoclonality assurance for regulatory submissions, and linking functional single-cell data to downstream TCR-seq, BCR-seq, and mRNA-seq.

Bruker Cellular Analysis generates revenue through a mix of high-value capital equipment sales, recurring consumable kits and chips tied to instrument placements, software subscriptions, and a fee-for-service Technology Access Program launched in 2024. Go-to-market is consultative enterprise field sales with quote-based pricing and no public list pricing. The unit operates within Bruker Corporation's larger life-science tools franchise and reports no independent financials, funding rounds, or M&A activity of its own.

Name

Bruker Cellular Analysis

Legal name

Bruker Cellular Analysis

Website

https://brukercellularanalysis.com

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

101–250 employees

Short description

Bruker Cellular Analysis, a subsidiary of Bruker Corporation, develops optofluidic (Beacon) and proteomic barcoding (IsoLight/IsoSpark) single-cell analysis instruments, consumables, and software used by academic, biopharma, CDMO, and cell therapy labs for antibody discovery, cell line development, and immune profiling.

Ownership category

akta.pro rank

Product category

Single-Cell Analysis Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835), Services-Testing Laboratories (8734)

akta.pro primary industry

Cell-Based & Potency Assays (Bioassays) (HLAGADAH)

akta.pro secondary industries

Proteomics & Biomarker Analytical Testing (HLAGADAG), Cell Therapy Quality, Analytics & Release Testing (potency, sterility, comparability) (HLAAABAK)

Keywords

• Single-cell analysis
• Optofluidic instruments
• Antibody discovery platforms
• Proteomic barcoding systems
• Cell biology reagents

Headquarters

HQ city

Emeryville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Optofluidic Instruments: Sale of Beacon platform instruments including Beacon Discovery, Beacon Quest, Beacon, and Beacon Select systems along with Culture Station for expanded throughput. These are high-value capital equipment purchases for single-cell analysis research.
2. Kits and Consumables: Recurring revenue from single-use OptoSelect chips, Antibody Discovery kits, Cell Line Development kits, T Cell Profiling kits, and various assay reagents. Customers must purchase compatible chips and reagents for each experimental run.
3. Software Licenses and Subscriptions: Cell Analysis Suite (CAS) software for Beacon instruments and IsoSpeak software for proteomic barcoding systems, providing recurring software revenue through licenses and service agreements.
4. Technology Access Program (TAP): Service offering where Bruker runs customer samples using Beacon Discovery in their state-of-the-art lab, delivering detailed reports with raw data and analyzed results within 8-10 weeks for researchers who want to access the technology without instrument purchase.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Bruker Cellular Analysis manufactures and sells single-cell analysis instruments and consumables built on proprietary optofluidic and proteomic barcoding technologies. Its Beacon Optofluidic platform enables live, high-throughput functional screening of single cells for antibody discovery, cell line development, and T cell profiling, while the IsoLight/IsoSpark Proteomic Barcoding Suite performs highly multiplexed single-cell cytokine and signaling proteomics. Revenue is generated through instrument sales, recurring chip and kit consumables, software licenses, and a service-based Technology Access Program.

Product overview

Bruker Cellular Analysis offers two integrated product platforms: the Optofluidic Product Suite (Beacon systems) for live single-cell functional analysis and the Proteomic Barcoding Suite (IsoLight/IsoSpark systems) for automated cellular proteomics. The Beacon platform includes four instruments (Beacon Discovery, Beacon Quest, Beacon, Beacon Select) supporting antibody discovery, T cell profiling, and cell line development applications, complemented by specialized kits (Antibody Discovery, Cell Line Development, T Cell Profiling) and Cell Analysis Suite software. The Proteomic Barcoding Suite features the IsoLight (high-capacity, 8-chip) and IsoSpark (compact, 4-chip) instruments running IsoCode chips for single-cell secretome and signaling analysis, CodePlex for walk-away bulk proteomics, and Meteor for quantitative bulk proteomics—all supported by IsoSpeak visualization software. Both platforms share common software ecosystems and enable multi-omics integration with downstream sequencing.

Differentiator

Problem solved

Functional benefit

Products and services

• Beacon Discovery Optofluidic System Compact benchtop optofluidic instrument that runs 1 chip with up to 20,000 single cells per run for immune profiling, cell therapy, and antibody/TCR/CAR discovery, targeted at academic, translational, and biotech labs.
• Beacon Quest Optofluidic System Mid-level throughput single-cell optofluidic instrument that runs up to 2 chips simultaneously (up to 40,000 NanoPens per run) for translational research, antibody discovery, and T cell profiling.
• Beacon Optofluidic System Flagship high-throughput single-cell optofluidic instrument that runs up to 4 chips simultaneously (up to 80,000 NanoPens per run) for large-scale antibody discovery, cell line development, and T cell profiling.
• Beacon Select Optofluidic System for Cell Line Development Specialized 2-chip optofluidic instrument for cell line development with positive-pressure biosafety, enabling monoclonality assessment, growth, productivity, quality, and stability screening for bioproduction workflows.
• Culture Station System Expansion module that transfers up to 4 OptoSelect chips to an independent culture module to free up Beacon and Lightning instruments during cell culture, enabling parallel processing with integrated media and fluidics.
• Beacon Discovery Technology Access Program (TAP) Service-based offering where researchers submit samples to Bruker's lab for analysis on the Beacon Discovery system, receiving detailed reports with raw and analyzed data within 8-10 weeks without capital purchase.
• Antibody Discovery Kit Comprehensive single B cell antibody discovery kit for the Beacon platform supporting plasma cells and memory B cells from human, mouse, rabbit, and alpaca species, including chips, reagents, and BCR recovery options for monoclonal antibody identification within a week.
• Cell Line Development Kit Kit for accelerating cell line development on the Beacon platform with up to 4x productivity boost and up to 50% timeline reduction, including reagents for productivity assays (Fc, Kappa, Lambda) and quality assays for CHO cells.
• T Cell Profiling Kit Kit for comprehensive single T cell functional profiling including dynamic cytotoxicity, multiplexed cytokine secretion, and surface marker phenotype for T cells, CAR-T cells, TCR-T cells, and TIL cells with downstream TCR-seq and scRNA-seq integration.
• Cell Analysis Suite (CAS) Software Software platform for designing, executing, and analyzing single-cell workflows on Beacon optofluidic instruments with pre-validated templates, real-time data analysis, image analysis, and assay analyzer tools.
• IsoLight System Automated proteomic barcoding hub that runs highly multiplexed single-cell proteomics workflows with up to 8 IsoCode chips per run (up to 8,000 single cells), featuring a fully automated ELISA workflow and walk-away operation.
• IsoSpark System Compact 18-inch-footprint functional proteomics system that runs up to 4 chips per run with a fully automated workflow, delivering walk-away single-cell proteomics with same-day data for any lab.
• Single-Cell Secretome (IsoCode Chip) Fully automated single-cell functional phenotyping solution for immune cells using IsoCode chips that detect 32+ cytokines per cell, covering human adaptive, inflammation, innate immune, and natural killer panels.
• Single-Cell Signaling (IsoCode Chip) Award-winning IsoCode chip for highly multiplexed phosphoprotein analysis at single-cell resolution, capturing intracellular protein-to-protein interactions and adaptive resistance pathways with 15+ analytes per cell.
• CodePlex Walkaway Proteomics Automated bulk cytokine analysis solution with only 5 minutes of hands-on time, measuring 32+ cytokines in bulk format using modular chips running 8 conditions per chip across 8 chips on IsoLight.
• Meteor Quantitative Bulk Proteomics Fully quantitative bulk proteomics solution running on the IsoSpark system, requiring only 7.5 µL sample volume per well with capacity for 20 samples in triplicate per chip (80 samples total per run).
• IsoSpeak Software Advanced data visualization software for IsoLight and IsoSpark systems providing automated on-site analysis, t-SNE visualizations, Polyfunctional Strength Index (PSI), and publication-ready data for single-cell cytokine profiling.

Quantifiable outcome

• Reduces antibody discovery timelines from months to hours with rapid single B cell screening
• +5 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

One partnership is on record.

• University of Texas at Arlington (IMPRINT)coreStrategic or Co-development Partner · 24 March 2026UTA became the first U.S. university to acquire the Beacon Discovery instrument for use at its Institute of Biomanufacturing and Precision Medicine for North Texas (IMPRINT). The partnership enables rapid single-cell analysis to accelerate antibody discovery and positions UTA as a regional center for biomanufacturing innovation while offering contract research services to biotech companies.

Recent moves6 records

Expansion highlights5 records

Direct peers

• 10x Genomics: 10x Genomics offers Chromium single-cell analysis platforms (RNA-seq, ATAC-seq, multi-ome) used by the same biopharma and academic research buyer as Bruker's Beacon. It is the closest competing platform for high-throughput single-cell isolation, omics, and functional characterization workflows.
• Standard BioTools: Standard BioTools (formerly Fluidigm) sells mass cytometry (Helios/Hyperion) and microfluidic single-cell tools targeting the same proteomics and cell biology research customers as Beacon and IsoLight/IsoSpark. Its Hyperion imaging system is a direct single-cell functional proteomics alternative to Bruker's IsoCode chips.
• Cytek Biosciences: Cytek's Aurora and Northern Lights spectral flow cytometers enable high-parameter single-cell immunophenotyping for the same T cell profiling and immune profiling applications as Beacon and the T Cell Profiling Kit. Both companies target translational immunology and cell therapy customers.
• Sony Biotechnology: Sony Biotechnology (CGX10 cell sorter, MA900 multi-application sorter) provides live single-cell isolation and high-throughput cell sorting for antibody discovery and cell therapy - both directly comparable to Beacon's automation-focused single-cell workflow.

Broad incumbents

• BD Biosciences: BD Biosciences is a major life sciences incumbent offering flow cytometry (BD FACSDiscover, BD CellView) and cell sorting used in similar antibody discovery and immunology workflows. While broader and more diversified, BD overlaps with Beacon in live single-cell analysis, antibody screening, and cell therapy characterization.
• Bio-Rad Laboratories: Bio-Rad's life science segment (ddPCR, S3 cell sorter, flow cytometry reagents, LabChip) competes in adjacent workflows for biopharma, CDMO and academic labs the same as Beacon and IsoLight. As a diversified incumbent, Bio-Rad offers alternatives across molecular and cell biology workflows.

Emerging players

• Mission Bio: Mission Bio's Tapestri platform performs single-cell multi-omics (DNA + protein) for clonal heterogeneity and rare cell characterization. While its primary focus is genomics-led multi-omics, its application areas (clonal screening, cell therapy QC) overlap with Beacon Select's monoclonality and cell line development capabilities.
• Parse Biosciences: Parse Biosciences offers Evercode single-cell RNA sequencing for fixed-sample, scalable workflows. While differentiated by sample handling and omics depth, it serves overlapping translational research and biopharma discovery customers evaluating single-cell platform decisions.
• Dolomite Bio (Blacktrace Bio): Dolomite Bio's Nadia and single-cell microfluidic instruments target antibody discovery and single-cell genomics applications. Its product line addresses similar B cell screening and cell line development workflows at smaller research scale, often competing for early-stage biotech placements.

Others

• Berkeley Lights (now part of PhenomeX/Bruker): Berkeley Lights pioneered the optofluidic single-cell platform that became Beacon after the PhenomeX rebrand and Bruker acquisition. It is the direct technological predecessor to Bruker Cellular Analysis' current product line and the source of the OEP/OptoSelect IP. Listed for completeness as the historical reference platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bruker Cellular Analysis